This website is best viewed in IE9 and above. Please upgrade your browser.X
Find out when studies you're interested in open or close, and when new information is postedget updates
If you would like to be contacted about this study by a doctor's office or clinic, please select a location and register below (if available).
Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear PalsyShare this Study
The purpose of this study is to evaluate the safety and tolerability of multiple ascending intravenous infusions of BMS-986168 and to assess the pharmacodynamics of BMS-986168 on cerebrospinal fluid (CSF) extracellular tau (eTau) concentrations in patients with Progressive Supranuclear Palsy.Full Study info
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.